Radiation Oncology/Therapy: Page 215

FDA clears ViewRay's MRI-guided RT system
By AuntMinnie.com staff writers
Image-guided therapy developer ViewRay announced it has received 510(k) clearance from the U.S. Food and Drug Administration for its MRI-guided radiation therapy (RT) system.
May 29, 2012
MRI visualizes proton dose distribution
By Tami Freeman
MRI visualizes the dose distribution with proton therapy procedures by imaging radiation-induced tissue changes, reducing the uncertainty of the range of the proton beam, according to a presentation at the recent European Society for Radiotherapy and Oncology annual meeting.
May 29, 2012
2012 05 29 15 29 02 229 2012 05 30 Estro Proton Mri Thumb
Standard Imaging rolls out software updates
By AuntMinnie.com staff writers
Radiation calibration and quality assurance company Standard Imaging has released updates to its PIPSpro and IMSure software packages.
May 29, 2012
ASTRO criticizes USPSTF stand on prostate screening
By AuntMinnie.com staff writers
The American Society for Radiation Oncology (ASTRO) has expressed its disappointment with the U.S. Preventive Services Task Force's (USPSTF) final recommendations against the use of prostate-specific antigen (PSA) screening for prostate cancer, and it cautioned against a blanket no-testing policy.
May 24, 2012
GE, Karolinska explore cell therapy
By AuntMinnie.com staff writers
GE Healthcare Life Sciences and Karolinska University Hospital in Sweden have formed a research collaboration to drive advances in cell therapy technologies.
May 21, 2012
Chemo with RT recommended for stage III lung cancer in elderly
By Cynthia E. Keen
The combination of chemotherapy and concurrent radiation therapy (RT) lengthened survival for elderly patients with unresectable stage III non-small cell lung cancer, according to a report by Japanese researchers published online May 22 in Lancet Oncology.
May 21, 2012
Proton therapy offers hope to pediatric brain cancer patients
By Cynthia E. Keen
At Massachusetts General Hospital, the Francis H. Burr Proton Therapy Center allocates 40% of its available treatment time to 10% of its cancer patients. Who are these patients? They're children fighting to survive and someday be able to live a normal life.
May 21, 2012
KLAS issues report on U.S. proton therapy market
By AuntMinnie.com staff writers
A report from market research firm KLAS suggests that concerns about market saturation and the estimated cost of $150 million to $200 million to build proton therapy centers will inhibit their proliferation in the U.S. over the next five years.
May 20, 2012
AuntMinnie.com Radiation Oncology Insider
By Cynthia E. Keen
May 16, 2012
QA records shed light on radiotherapy patient errors
By Jacqueline Hewett
The computerization of radiation therapy planning and treatment can be a double-edged sword, both reducing and increasing the risk of errors. But computerization does make treatment safer, according to a 10-year analysis of errors at Memorial Sloan-Kettering Cancer Center in New York City.
May 16, 2012
2009 01 15 16 03 49 510 Med Phys Web Logo 100
Study reports APBI is effective for treating DCIS
By Cynthia E. Keen
Accelerated partial-breast irradiation (APBI) brachytherapy appears to be an effective treatment for patients diagnosed with ductal carcinoma in situ (DCIS), according to a study presented at the American Society of Breast Surgeons annual meeting held in Phoenix last week.
May 10, 2012
ESTRO: Study positive about APBI brachytherapy
By Cynthia E. Keen
Accelerated partial-breast irradiation (APBI) brachytherapy produces comparable local recurrence outcomes with much better cosmesis compared to whole-breast irradiation, according to research presented on Friday at the European Society for Radiotherapy and Oncology (ESTRO) World Congress of Brachytherapy in Barcelona, Spain.
May 10, 2012
2012 05 11 08 45 38 978 Csaba Polgar 70
Previous Page
Page 215 of 464
Next Page